Source: Virtual Congress 2021 – Hot news from the pleura



Rating:

Share or cite this content

Citations should be made in the following way:
E. Grabczak (Warszawa, Poland). Optimal management of symptomatic malignant pleural effusions: individualised care. Virtual Congress 2021 – Hot news from the pleura

Member's Comments

No comment yet.

Related content which might interest you: Are patients with malignant pleural effusions being referred appropriately for surgical intervention? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Ambulatory management of malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 629s Year: 2004 Thoracoscopic palliative treatment of malignant pleural effusions Source: Annual Congress 2011 - A little bit of everything: interventional pneumology Year: 2011 ERS/EACTS statement on the management of malignant pleural effusions Source: Eur Respir J, 52 (1) 1800349; 10.1183/13993003.00349-2018 Year: 2018 ERS/EACTS statement on the management of malignant pleural effusions Source: Guideline 2018 Year: 2018 Optimal diagnosis and treatment of malignant pleural disease: challenging the guidelines Source: Eur Respir Monogr 2020; 87: 138-154 Year: 2020 ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Guideline 2020 Year: 2020 ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019 Year: 2020 Malignant pleural effusions: from the diagnosis to the management Source: International Congress 2015 – ME2 Malignant pleural effusions: from diagnosis to management Year: 2015 Malignant pleural effusions: diagnosis and management Source: International Congress 2017 – PG5 Pleural disease management Year: 2017 A Dutch web-survey on management of malignant pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Management of recurrent transudative pleural effusions: can we REDUCE unnecessary interventions? Source: Eur Respir J, 59 (2) 2101942; 10.1183/13993003.01942-2021 Year: 2022 The importance of intrapleurally γ-interferon in ambulatory management of malignant pleural effusion in elderly patients with end-stage NSCCL Source: Eur Respir J 2005; 26: Suppl. 49, 495s Year: 2005 Predictors of successful pleurodesis for patients with malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 493s Year: 2004 Impact of indwelling pleural catheter on quality of life in management of malignant pleural effusion in patients with advanced malignancies Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Optimal treatment of pleurodesis for malignant pleural effusion in 2017 Source: ERS Skills course - Medical thoracoscopy Year: 2017 The management of benign non-infective pleural effusions Source: Eur Respir Rev 2016; 25: 303-316 Year: 2016 Multimodal management of malignant pleural mesothelioma: where are we today? Source: Eur Respir J 2014; 44: 754-764 Year: 2014 Management of recurrent malignant pleural effusions Source: ERS Skills Course 2017 - Thoracoscopy and Pleural Techniques Year: 2017